
Regen Biosystems Private Limited
About Regen Biosystems Private Limited
Data last updated:
Regen Biosystems Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the diversified business activities segment of the business services sector. It was incorporated on 24 January 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74900MH2014PTC252460. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Aakash Naresh Jethwani and Chitra Jethwani Aakash.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 5 First Floor Surya Mahal Building Burjorji Bharucha Marg Fort, Mumbai, Maharashtra, India – 400001.
As per the financials filed for FY 2022, the company reported a revenue of ₹14,861, a decline of 99% compared to the previous year. For the same year it recorded a net loss of ₹36,496 (net margin -245.6%) and EBITDA of -₹42,330 (EBITDA margin -284.8%). Revenue has declined at a compounded annual rate (CAGR) of 82% over three years.
Its group structure includes 1 subsidiary.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Regen Biosystems Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address5 First Floor Surya Mahal Building Burjorji Bharucha Marg Fort, Mumbai, Maharashtra, India – 400001
- IndustryBusiness Services, Miscellaneous Business Activities
To see the full contact details of Regen Biosystems Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Regen Biosystems is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Regen Biosystems Private Limited, buy the company report.
Financials of Regen Biosystems Private Limited
FY 2025 filings availableRegen Biosystems Private Limited reported revenue of ₹14,861 (down 99% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 82% over three years, including a 99% fall in the latest year. EBITDA fell 104% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹42,330 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹36,496 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -284.8% | ||||
| Net Profit Margin | -245.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Regen Biosystems Private Limited, buy the company report.
Board of directors of Regen Biosystems Private Limited
Regen Biosystems has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aakash Naresh Jethwani | Director | 29 Oct 2018 | 8 Years 0 Months | Current |
| Chitra Jethwani Aakash | Director | 15 May 2021 | 5 Years 6 Months | Current |
Peer comparison
Regen Biosystems Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Profusha Global Nature Private Limited | ₹16,133 (FY 2024) | -87.0% | Lucknow, Uttar Pradesh, India | |||
| Balak Nath Kripa Private Limited | ₹15,510 (FY 2025) | -77.0% | Noidaextension, Uttar Pradesh, India | |||
| Avnsac Global Private Limited | ₹15,270 (FY 2025) | 11.0% | Yamuna Nagar, Haryana, India | |||
| Gaillardia Pharmaceuticals Private Limited | ₹15,029 (FY 2025) | Vikasnagar, Uttarakhand, India | ||||
| Trugrace Pharmaceuticals Private Limited | ₹15,009 (FY 2025) | Kadi, Gujarat, India | ||||
| Regen Biosystems Private Limitedthis company | ₹14,861 (FY 2022) | -₹36,496 | -245.6% | -99.0% | Mumbai, Maharashtra, India | |
| Allgenix Pharmaceuticals (OPC) Private Limited | ₹14,095 (FY 2025) | Budhana, Uttar Pradesh, India | ||||
| Aarti Pharmaceuticals Private Limited | ₹12,211 (FY 2025) | New Delhi, Delhi, India | ||||
| Alveoli Private Limited | ₹11,864 (FY 2025) | -39.0% | Kamrup, Assam, India | |||
| Healthzone Pharmacy Private Limited | ₹11,610 (FY 2025) | -99.0% | Khed, Maharashtra, India | |||
| Albizia Pharmachem Private Limited | ₹10,000 (FY 2025) | Beed, Maharashtra, India |
To see the full peer comparison of Regen Biosystems Private Limited, buy the company report.
Auditor
Regen Biosystems Private Limited is audited by Nihar Mehta & Co for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Nihar Mehta & Co | FY 2017 | 134646W |
Shareholding
The shareholding of Regen Biosystems Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Regen Biosystems Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Regen Biosystems Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Regen Biosystems Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Regen Biosystems has 1 subsidiary company. This group structure data is as of FY 2017. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Artha Venture Services Private Limited | U74999MH2013PTC249076 |
To see the full group structure of Regen Biosystems Private Limited, buy the company report.
GST
Regen Biosystems has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Regen Biosystems Private Limited, buy the company report.
Recent activity
Regen Biosystems Private Limited has 6 board changes on record since 2018: 2 appointments and 4 cessations. The latest: Anirudh Ashokkumar Damani ceased to be Director on 14 Oct 2022.
Frequently asked questions
Regen Biosystems is an active private limited company based in Mumbai, Maharashtra, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 24 January 2014 (12+ years old) and is registered under CIN U74900MH2014PTC252460.
Regen Biosystems has 2 current directors:
- Aakash Naresh Jethwani - Director
- Chitra Jethwani Aakash - Director
The latest financial statements of Regen Biosystems on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Regen Biosystems has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Regen Biosystems is U74900MH2014PTC252460. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Regen Biosystems was incorporated on 24 January 2014, making it 12+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Regen Biosystems by revenue are Profusha Global Nature Private Limited, Balak Nath Kripa Private Limited, Avnsac Global Private Limited, Gaillardia Pharmaceuticals Private Limited, Trugrace Pharmaceuticals Private Limited and 5 more, all in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations).
Anirudh Ashokkumar Damani ceased to be Director on 14 Oct 2022. Ashok Kumar Kishori Lal Damani ceased to be Director on 14 Oct 2022. Chitra Jethwani Aakash ceased to be Additional Director on 30 Nov 2021. Regen Biosystems has 6 board changes on record in total.
The registered office of Regen Biosystems is at 5 First Floor Surya Mahal Building Burjorji Bharucha Marg Fort, Mumbai, Maharashtra, India – 400001.
Regen Biosystems operates in the business services industry, in the miscellaneous business activities segment.
The compliance status of Regen Biosystems is compliant as of 28 September 2026. The company is actively filing with the Registrar of Companies.

